| Product Code: ETC6893158 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of drug-device combination products to Cyprus showed steady growth in 2024, with top exporting countries being Greece, Germany, Netherlands, Switzerland, and Vietnam. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained at a moderate level. The compound annual growth rate (CAGR) from 2020 to 2024 was robust at 10.34%, indicating a positive trend in the market. Additionally, the growth rate in 2024 accelerated to 13.05%, suggesting increased demand and potential opportunities for market expansion in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus Drug-Device Combination Products Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus Drug-Device Combination Products Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus Drug-Device Combination Products Market - Industry Life Cycle |
3.4 Cyprus Drug-Device Combination Products Market - Porter's Five Forces |
3.5 Cyprus Drug-Device Combination Products Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Cyprus Drug-Device Combination Products Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Cyprus Drug-Device Combination Products Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Cyprus Drug-Device Combination Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and targeted therapies |
4.2.2 Growing prevalence of chronic diseases requiring advanced treatment options |
4.2.3 Technological advancements in drug-device combination products leading to improved patient outcomes |
4.2.4 Favorable regulatory environment supporting the development and commercialization of such products |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and market access of drug-device combination products |
4.3.2 High development costs and lengthy approval processes |
4.3.3 Limited awareness and understanding among healthcare professionals and patients about the benefits of these products |
4.3.4 Potential safety and efficacy concerns associated with complex combination therapies |
5 Cyprus Drug-Device Combination Products Market Trends |
6 Cyprus Drug-Device Combination Products Market, By Types |
6.1 Cyprus Drug-Device Combination Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting stents, 2021- 2031F |
6.1.4 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Infusion pumps, 2021- 2031F |
6.1.5 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Photodynamic therapy, 2021- 2031F |
6.1.6 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial wound dressings, 2021- 2031F |
6.1.7 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Prefilled syringes, 2021- 2031F |
6.1.8 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting balloons, 2021- 2031F |
6.1.9 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Other, 2021- 2031F |
6.1.10 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Other, 2021- 2031F |
6.2 Cyprus Drug-Device Combination Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Cardiovascular Disorders, 2021- 2031F |
6.2.3 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.2.4 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Respiratory Problems, 2021- 2031F |
6.2.5 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Cancer Treatment, 2021- 2031F |
6.2.6 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial Application, 2021- 2031F |
6.2.7 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Cyprus Drug-Device Combination Products Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Hospital & clinic, 2021- 2031F |
6.3.3 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Ambulatory surgery center (asc), 2021- 2031F |
6.3.4 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Home care setting, 2021- 2031F |
6.3.5 Cyprus Drug-Device Combination Products Market Revenues & Volume, By Other, 2021- 2031F |
7 Cyprus Drug-Device Combination Products Market Import-Export Trade Statistics |
7.1 Cyprus Drug-Device Combination Products Market Export to Major Countries |
7.2 Cyprus Drug-Device Combination Products Market Imports from Major Countries |
8 Cyprus Drug-Device Combination Products Market Key Performance Indicators |
8.1 Adoption rate of drug-device combination products by healthcare facilities and providers |
8.2 Number of clinical trials and research studies involving drug-device combination products |
8.3 Patient satisfaction and outcomes data related to the use of these products |
8.4 Investment trends in research and development of innovative drug-device combination products |
8.5 Regulatory approvals and market authorizations granted for new products in the market |
9 Cyprus Drug-Device Combination Products Market - Opportunity Assessment |
9.1 Cyprus Drug-Device Combination Products Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Cyprus Drug-Device Combination Products Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Cyprus Drug-Device Combination Products Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Cyprus Drug-Device Combination Products Market - Competitive Landscape |
10.1 Cyprus Drug-Device Combination Products Market Revenue Share, By Companies, 2024 |
10.2 Cyprus Drug-Device Combination Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here